Morphine sulfate and Hibiclens drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Morphine sulfate (morphine sulfate) and Hibiclens (chlorhexidine gluconate). Common drug interactions include atelectasis among females and arrhythmia among males.

The phase IV clinical study analyzes what interactions people have when they take Morphine sulfate and Hibiclens. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Morphine sulfate?

Morphine sulfate has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 87,262 Morphine sulfate users. Check the latest studies of Morphine sulfate.

What is Hibiclens?

Hibiclens has active ingredients of chlorhexidine gluconate. eHealthMe is studying from 536 Hibiclens users. Check the latest studies of Hibiclens.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

14 people who take Morphine sulfate and Hibiclens together, and have interactions are studied.

Morphine sulfate and Hibiclens drug interactions.

What are the common drug interactions of Morphine Sulfate and Hibiclens, by gender? *:

female:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Dyspnoea (difficult or laboured respiration)
  3. Pain in extremity
  4. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
  7. Cardiac failure
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Heart rate decreased
  10. Hypotension (abnormally low blood pressure)

male:

  1. Arrhythmia (irregular heartbeat)
  2. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  3. Hepatic failure (liver failure)
  4. Liver disorder (liver diseases)
  5. Pulmonary hypertension (increase in blood pressure in the lung artery)
  6. Renal failure acute (rapid kidney dysfunction)
  7. Septic shock (shock due to blood infection)
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Pneumonia

What are the common drug interactions of Morphine Sulfate and Hibiclens, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Dyspnoea (difficult or laboured respiration)
  3. Pain in extremity
  4. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
  7. Cardiac failure
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Injury

40-49:

n/a

50-59:

  1. Arrhythmia (irregular heartbeat)
  2. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  3. Hepatic failure (liver failure)
  4. Liver disorder (liver diseases)
  5. Pulmonary hypertension (increase in blood pressure in the lung artery)
  6. Renal failure acute (rapid kidney dysfunction)
  7. Septic shock (shock due to blood infection)
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Pneumonia

60+:

n/a

What are the existing conditions these people have? *

  1. Hiv Infection: 2 people, 14.29%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.14%
  3. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 7.14%
  4. Birth Control: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Morphine sulfate and Hibiclens?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Morphine sulfate and Hibiclens:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Morphine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hibiclens:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Morphine sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hibiclens and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate and chlorhexidine gluconate (the active ingredients of Morphine sulfate and Hibiclens, respectively), and Morphine sulfate and Hibiclens (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: